Viewing a single comment thread. View all comments

WoolyLawnsChi t1_jdw392l wrote

>the thickness of cancer cells' glycocalyx is one of the major parameters determining immune cell evasion and engineered immune cells work better if the glycocalyx is thinner.
>
>As a result of these findings the researchers then engineered immune cells with special enzymes on their surface to allow them to attach to and interact with the glycocalyx. They then found that these specialized immune cells were able to overcome the glycocalyx armor of cancer cells,

If I am reading this correctly the discovery isn't some new "drug"

instead it will make existing immunotherapies more effective

28

Phoenix5869 t1_jdw9fnf wrote

> it will make existing immunotherapies more effective

That’s good to hear, but it’s a far cry from what the title implies

6

ConversationOk4414 t1_jdzgzfa wrote

They’ve successfully eradicated a form of cancer (I don’t remember which) in their entire study group using this technique.

1

Solid_Hunter_4188 t1_jdw7gdn wrote

Sounds like a selection/gene therapy done specifically to tcell or NK’s to either increase the number of detectors or improve binding of existing MHC

3

Brain_Tourismo t1_jdyxij3 wrote

I thought they had engineered enzymes onto the existing NKs, no? Sure it is an extra step but well worth it.

1